3. INTRODUCTION
• Suppuration in the “preexisting space” between the dura and arachnoid.
• Also known as – Pachymeningitis Interna/ Purulent Pachymeningitis.
• Serious illness associated with frequent neurologic sequalae , resulting in
mortality rates up to 10-20%.
• It constitutes to about 13-23% of all the intracranial bacterial infections &
presents as a fulminant picture
• Surgical Emergency
8. ETIOLOGY
• Most commonly supratentorial
• Generally as secondary spread
• Paranasal sinus infection – (40-80%)- Retrograde thrombosis/ Direct Spread
• Otitis Media/ Mastoiditis – (10-20%)- Direct Spread- Temporal & Occipital
• Trauma/ Iatrogenic – 20%- Less fulminant,
• Subdural Effusion
• Meningitis- Neonates (2-10%) The mechanism of the development in infants is
through infection of sterile, reactive subdural effusions secondary to meningitis.
• Hematogenous (distant) – 5% of the cases.
10. CLINICAL FEATURES
• Usually Dramatic/ Fulminant
• Mainly due to the Bacterial Toxins & Cortical Venous Thrombosis – Infarction.
• Altered Sensorium
• Features of Raised ICP – (Cerebral Oedema & Hydrocephalus)
• Speech disturbances/ Hemiparesis/ Seizures may also been seen
• Generally symptoms to diagnosis is usually 4 days
• Diagnosed Clinically – High Index of suspicion.
• Post OP- Sepsis + Seizures ( 25%), Generally by 1 month
11.
12. • Therefore the clinical features of the Subdural Empyema is due to
• 1) Features of Raised ICP
• 2) Meningeal Irritation ( 80%)
• 3) Focal Cortical Inflammation
• * In cases secondary to Post OP, Previous Antibiotic, Infected Subdural Hematoma
& Hematogenous – Patients are generally less symptomatic & presents with
seizures.
13. PATHOPHYSIOLOGY
• Subdural empyema most often occurs due to the direct extension of local
infection.
• The infection can spread to the intracranial compartment due to the valveless
diploic veins of Breschet.
• As a result, blood may flow in either direction, causing the spread of bacterial
infection intracranially
• They can also occur after cranial surgical procedures secondary to the inoculation
of microorganisms into the subdural space, further developing into a subdural
empyema.
14. • Fulminant Nature of the Subdural Empyema
• 1) Lack of Fibrin Capsule within the subdural space
• 2) Lack of Anatomical Barriers.
17. INVESTIGATIONS
• Blood Routine –Leukocytosis with Left sided shift - Neutrophils
• CRP/ ESR – Inflammatory Markers.
• Blood Culture
• LP – Not Indicated.
• Imaging
18.
19. IMAGING
• CT Head- When using CT as an imaging modality, SDE will appear crescentic in shape over the
cerebral convexity with a surrounding rim that is enhanced with the use of contrast.
• MRI Brain – The diagnostic imaging study of choice for intracranial subdural empyema is a
magnetic resonance imaging (MRI) with intravenous gadolinium enhancement
• High signal Intensity on DWI, Low signal on ADC, ADC Value less than normal cortical Grey
Matter
• Diffusion MRI – Can differentiate between Subdural Empyema and Subdural Effusion.
29. MANAGEMENT
• Neurosurgical emergency
• Early Surgery – Craniotomy/ Craniectomy/ Evacuation of Empyema
• Followed by Antibiotics
• Vancomycin + 3rd Generation Cephalosporins
• Continued for 4 to 6 weeks & A follow up scan to be planned during this period
34. EPIDURAL ABSCESS
• Between the skull & Dura
• Generally in frontal region – as a result of contiguous spread from PNS
• Indolent Lesion ( Dura Mater protects the brain )
• Fever/ Headache/ Neurologic Signs – Due to the mass effect rather than
infiltration.
• Treatment is mainly conservative with antibiotics
• If Untreated- It can spread intracranially – Septic Thrombophlebitis
• MRI Shows – Thickened Dural Surface.
35. SUBDURAL HYGROMA
• Excess fluid in the subdural space (may be clear, blood tinged, or xanthochromic and
under variable pressure).
• Mechanism of formation of hygroma is probably a tear in the arachnoid membrane
with resultant CSF leakage into the subdural compartment. Hygroma fluid contains
pre-albumin, which is also found in CSF but not in subdural hematomas.
• Another possible mechanism is post-meningitis effusion.
• May increase in size (possibly due to a flap-valve mechanism)
• On CT, the density of the fluid is similar to that of CSF.
• Signal characteristics on MRI follow those of CSF
36. SUBDURAL EFFUSION/ CHRONIC SDH
• Classically CSDHs contain dark “motor oil” fluid which does not clot.
• Blood within the subdural space evokes an inflammatory response. Within days,
fibroblasts invade the clot and form neomembranes on the inner (cortical) and
outer (dural) surface.
• This is followed by ingrowth of neocapillaries, enzymatic fibrinolysis, and
liquefaction of blood clot.
• Patients may present with minor symptoms of headache, confusion, language
difficulties (e.g. word Finding difficulties or speech arrest, usually with dominant
hemisphere lesions), or TIA-like symptoms
37. CEREBRAL ABSCESS
• Adults: no findings are specific for abscess, and many are due to edema
surrounding the lesion.
• Most symptoms are due to increased ICP (H/A, N/V, lethargy). Hemiparesis and
seizures develop in 30–50% of cases. Symptoms tend to progress less rapidly than
with empyema
• It takes at least 2 weeks to progress through this maturation process,
• Diffusion MRI: DWI → bright, ADC → dark (restricted diffusion suggesting viscous
fluid)